$INSM News

Insmed (INSM) Q2 2026 Earnings Call Transcript

JP Morgan Maintains Overweight on Insmed, Lowers Price Target to $175

Truist Securities Reiterates Buy on Insmed, Raises Price Target to $195

$1000 Invested In Insmed 5 Years Ago Would Be Worth This Much Today

Has Insmed (INSM) Risen Above Fair Value After Its 3 Year Run?

Guggenheim Maintains Buy on Insmed, Lowers Price Target to $205

Insmed Incorporated Q2 2026 Earnings Call Summary

Wells Fargo Maintains Overweight on Insmed, Raises Price Target to $169

Evercore ISI Group Maintains Outperform on Insmed, Raises Price Target to $170

Insmed (INSM) Is Up 30.6% After Steeply Narrowing Losses And Raising 2026 Revenue Guidance – What’s Changed

Insmed (INSM) Soars 33.86% as Brinsupri Drives Fourfold Growth. Here’s What to Watch Next

Insmed Inc (INSM) (Q2 2026) Earnings Call Highlights: BRINSUPRI Surges 49% Sequentially, ...

Insmed Q2 Earnings Call Highlights

Insmed Raises BRINSUPRI Revenue Guidance After Strong Q2 Growth and Expands Peak Sales Outlook

Insmed (INSM) Reports Q2 Earnings: What Key Metrics Have to Say

Insmed (INSM) Reports Q2 Loss, Tops Revenue Estimates

Insmed Incorporated (INSM) Q2 2026 Earnings Call Transcript

Insmed Reports Second-Quarter 2026 Financial Results and Provides Business Update

Insmed Incorporated 2026 Q2 - Results - Earnings Call Presentation

Insmed Q2 EPS $(0.06) Beats $(0.73) Estimate, Sales $425.486M Beat $392.836M Estimate